AdaptHealth Corp. $AHCO Shares Bought by Allianz Asset Management GmbH

Allianz Asset Management GmbH raised its position in AdaptHealth Corp. (NASDAQ:AHCO) by 127.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 167,279 shares of the company’s stock after acquiring an additional 93,779 shares during the quarter. Allianz Asset Management GmbH owned 0.12% of AdaptHealth worth $1,577,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. New York State Teachers Retirement System grew its position in AdaptHealth by 12.9% in the second quarter. New York State Teachers Retirement System now owns 90,794 shares of the company’s stock valued at $856,000 after acquiring an additional 10,339 shares in the last quarter. CWM LLC grew its position in AdaptHealth by 1,562.1% in the second quarter. CWM LLC now owns 10,471 shares of the company’s stock valued at $99,000 after acquiring an additional 9,841 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its position in shares of AdaptHealth by 21.6% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 19,307 shares of the company’s stock worth $182,000 after buying an additional 3,436 shares in the last quarter. Janney Montgomery Scott LLC grew its position in shares of AdaptHealth by 1.9% during the second quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock worth $757,000 after buying an additional 1,511 shares in the last quarter. Finally, SummerHaven Investment Management LLC grew its position in shares of AdaptHealth by 2.4% during the second quarter. SummerHaven Investment Management LLC now owns 81,771 shares of the company’s stock worth $771,000 after buying an additional 1,888 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Performance

AHCO stock opened at $9.37 on Friday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. The stock has a market capitalization of $1.27 billion, a price-to-earnings ratio of 17.35, a PEG ratio of 1.16 and a beta of 1.61. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.63. The stock’s fifty day moving average is $9.17 and its two-hundred day moving average is $9.00.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of AdaptHealth in a research report on Friday. Wall Street Zen raised shares of AdaptHealth from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 19th. Finally, Zacks Research downgraded shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research report on Friday, September 19th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.40.

Insider Transactions at AdaptHealth

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $9.73, for a total value of $79,786.00. Following the sale, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.55% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.